Indigenous Medical Device Gets European Nod for Export

It was announced that an indigenously manufactured haematology analyser has become the first Indian product in its category to get a certification for export to European markets.

According to a statement released by Trivitron Healthcare, Cellenium 19, the indigenously manufactured haematology analyser (device used to analyze blood disorders or blood counts) has become first Indian designed and manufactured haematology analyser to have CE certificate, that enables it to become the first such analyser fit for export to the European Union countries.

Telomerase- The Key To Cell Replication
The key component to cell replication has been identified as telomerase, which is a high-priority target for many diseases.

For India-based users of Cellenium 19, this development means complete assurance of operator safety and harmonisation with internationally accepted clinical standards.

For large laboratories using Cellenium 19, it will also ensure smooth compliance to national and international accreditations like NABH, NABL and CAP.

Founder and managing director of Trivitron Healthcare G.S.K. Velu said: "We are glad to get the CE certificate for Cellenium 19 as it requires high quality manufacturing processes to be followed as per European standards."

Intravenous �blood Thinner� Safe for Sickle Cell Patients
A potentially promising drug appears to be well tolerated in sickle cell patients. The results gives the impetus to go ahead with further studies.

Source-IANS

GM Crops Cannot be Completely Abandoned by India: Jaipal Reddy
Minister Jaipal Reddy announced on Wednesday that India cannot afford to completely abandon GM crops and that the government is trying to reach at a solution soon.

Indian Investment in Healthcare Welcomed in African Countries
A number of African countries are welcoming investment from India in tertiary healthcare and supply of affordable medicines to their populations.